glp-1 natural agonist Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways GLP-1 receptor agonists for individualized

Tirzepatide as an insulin sensitizer

Retatrutide, Eli Lillys latest weight management and diabetes drug, appears to have outperformed the companys current product, tirzepatide (Mounjaro, Zepbound), in clinical trials

Numerous gastrointestinal conditions, such as irritable bowel syndrome, inflammatory bowel disease, and small intestinal bacterial overgrowth, have been associated with dysbiosis (an imbalance or disruption in the composition and diversity of the gut microbiome) [111]

This reaction is severe and potentially life-threatening, including symptoms like unease, tingling, dizziness, itching, hives, swelling, difficulty breathing, and fainting

Liraglutide in type 2 diabetes mellitus: clinical pharmacokinetics and pharmacodynamics

Lassen, M